Rat Anti-ADAM19 Recombinant Antibody (V2-179769) (CBMAB-A1131-YC)

Wang, J., Nie, W., Xie, X., Bai, M., Ma, Y., Jin, L., ... & Han, F. (2021). MicroRNA-874-3p/ADAM (A Disintegrin and Metalloprotease) 19 Mediates Macrophage Activation and Renal Fibrosis After Acute Kidney Injury. Hypertension, 77(5), 1613-1626.

Kang, T. Z. E., Zhu, L., Yang, D., Ding, D., Zhu, X., Wan, Y. C. E., ... & Chan, K. M. (2021). The elevated transcription of ADAM19 by the oncohistone H2BE76K contributes to oncogenic properties in breast cancer. Journal of Biological Chemistry, 296.

Li, H., Nichols, C., Gruzdev, A., House, J. S., Ward, J., Li, J., ... & London, S. (2020). ADAM19 and Pulmonary Function in the Mouse: Follow-Up of Human GWAS. In A67. STRUCTURE-FUNCTION RELATIONSHIPS (pp. A2386-A2386). American Thoracic Society.

Xu, S., Huang, S., Li, D., Zou, Q., Yuan, Y., & Yang, Z. (2020). Comparison of ADAM19 and CUEDC2 expression in EHCC and their clinicopathological significance. Biomarkers in Medicine, 14(16), 1573-1584.

Weerasekera, L., Rudnicka, C., Sang, Q. X., Curran, J. E., Johnson, M. P., Moses, E. K., ... & Matthews, V. B. (2017). ADAM19: a novel target for metabolic syndrome in humans and mice. Mediators of inflammation, 2017.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols

Isotype control